Several components involved in catalysing/erasing/reading H2AK119ub1 are recurrently mutated in myeloid disorders such as AML, including ASXL1, DNMT3A, BCOR and BCORL1 (Dohner et al., 2017). This evidence concerns the gene ASXL1 and acute myeloid leukemia.